Five months after giving up on its lead drug Betalutin for follicular lymphoma, Nordic Nanovector has charted a course forward via a merger with fellow Norwegian biotech APIM Therapeutics.

This is a gradle plugin for building modular assertions. For an example usage see the helloworld assertion: https://github.com/ca-api-gateway-extensions/helloworld ...